Insider · CIK 0001699737

Samsara BioCapital, L.P.

CIK 0001699737 Name as filed on the most recent filing

Filed as Samsara BioCapital, L.P. (17)

28 transaction lines · from 17 filings · filed 2021-07-01 to 2026-05-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-20 P, Open-market purchase Kalaris Therapeutics, Inc.KLRS 1,179,969, acquired Open Form 4 filing 0001231919-26-000532
2025-12-18 P, Open-market purchase Kalaris Therapeutics, Inc.KLRS 5,000,006, acquired Open Form 4 filing 0001231919-26-000166
2025-03-13 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 8,100,000, acquired Open Form 4 filing 0001415889-25-008275
2024-11-26 P, Open-market purchase Neurogene Inc.NGNE 4 lines 1,259,623, acquired Open Form 4 filing 0001415889-24-027861
2024-05-30 P, Open-market purchase Cargo Therapeutics, Inc.CRGX 4,998,000, acquired Open Form 4 filing 0001415889-24-015250
2024-02-12 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 7,499,993, acquired Open Form 4 filing 0001415889-24-003859
2023-11-14 P, Open-market purchase Cargo Therapeutics, Inc.CRGX 9,999,990, acquired Open Form 4 filing 0001209191-23-055621
2023-10-16 P, Open-market purchase Scholar Rock Holding CorpSRRK 15,000,000, acquired Open Form 4 filing 0001209191-23-053111
2023-02-14 P, Open-market purchase Mineralys Therapeutics, Inc.MLYS 15,000,000, acquired Open Form 4 filing 0001628280-23-003923
2022-04-12 P, Open-market purchase Graphite Bio, Inc.GRPH 1,428,000, acquired Open Form 4 filing 0001209191-22-024364
2022-04-11 P, Open-market purchase Graphite Bio, Inc.GRPH 303,068, acquired Open Form 4 filing 0001209191-22-024364
2022-01-24 P, Open-market purchase Graphite Bio, Inc.GRPH 200,100, acquired Open Form 4 filing 0001209191-22-004735
2022-01-21 P, Open-market purchase Graphite Bio, Inc.GRPH 899,000, acquired Open Form 4 filing 0001209191-22-004735
2022-01-20 P, Open-market purchase Graphite Bio, Inc.GRPH 384,497, acquired Open Form 4 filing 0001209191-22-004346
2022-01-19 P, Open-market purchase Graphite Bio, Inc.GRPH 504,181, acquired Open Form 4 filing 0001209191-22-004346
2021-12-15 P, Open-market purchase Graphite Bio, Inc.GRPH 227,533, acquired Open Form 4 filing 0001209191-21-070500
2021-11-22 P, Open-market purchase Graphite Bio, Inc.GRPH 2,047,103, acquired Open Form 4 filing 0001209191-21-066742
2021-10-15 P, Open-market purchase Graphite Bio, Inc.GRPH 28,727, acquired Open Form 4 filing 0001209191-21-060627
2021-10-14 P, Open-market purchase Graphite Bio, Inc.GRPH 38,750, acquired Open Form 4 filing 0001209191-21-060627
2021-10-13 P, Open-market purchase Graphite Bio, Inc.GRPH 600,188, acquired Open Form 4 filing 0001209191-21-060627
2021-10-08 P, Open-market purchase Graphite Bio, Inc.GRPH 984,000, acquired Open Form 4 filing 0001209191-21-060060
2021-10-07 P, Open-market purchase Graphite Bio, Inc.GRPH 134,774, acquired Open Form 4 filing 0001209191-21-060060
2021-10-06 P, Open-market purchase Graphite Bio, Inc.GRPH 850,199, acquired Open Form 4 filing 0001209191-21-060060
2021-06-29 P, Open-market purchase Graphite Bio, Inc.GRPH 2 lines 8,500,000, acquired Open Form 4 filing 0001209191-21-044507

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Samsara BioCapital, L.P., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001699737

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.